Editor LSA

Hot Stock's Alert: Frontier Communications Corp (NASDAQ:FTR), MannKind Corporation (NASDAQ:MNKD), Dyax Corp. (NASDAQ:DYAX), Prospect Capital Corporation (NASDAQ:PSEC)

 

Lewes, DE -- (SBWIRE) -- 10/29/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Frontier Communications Corp (NASDAQ:FTR), MannKind Corporation (NASDAQ:MNKD), Dyax Corp. (NASDAQ:DYAX), Prospect Capital Corporation (NASDAQ:PSEC)

Frontier Communications Corp (NASDAQ:FTR) opened its shares at the price of $4.48 for the day. Its closing price was $4.49 after gaining +0.22% for the day. The company traded with the total volume of 3.98 million shares, while its average trading volume remained 7.50 million shares. The beta of FTR stands at0.81. Frontier Communications Corporation, a communications company, provides regulated and unregulated voice, data, and video services to business, residential, and wholesale customers in the United States.

Why Should Investors Buy FTR After The Recent Gain? Just Go Here and Find Out

MannKind Corporation (NASDAQ:MNKD) percentage change plunged -1.60% to close at $5.24 with the total traded volume of 3.94 million shares, and average volume of 5.00 million. The 52 week range of the stock remained $1.85 - $8.70, while its day lowest price was $5.12 and it hit its day highest price at $5.42. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.

Has MNKD Found The Bottom and Ready To Move Up? Find Out Here

Dyax Corp. (NASDAQ:DYAX) started its trading session with the price of $6.95 and closed at $7.58 by scoring +8.75%. DYAX’s stocks traded with total volume of 3.46 million shares, while the average trading volume remained 1.30 million shares. The beta of DYAX stands at 1.69. Day range of the stock was $6.66 -$7.61. Dyax Corp., a biopharmaceutical company, engages in the identification, development, and commercialization of treatments for plasma kallikrein-mediated (PKM) angioedemas.

For How Long DYAX will Fight for Profitability? Read This Trend Analysis report

Prospect Capital Corporation (NASDAQ:PSEC) ended its day with the loss of -0.10% and closed at the price of $11.46 after opening at $11.48. Stock traded during its last trading session with the total volume of 3.72 million shares, as compared to its average volume of 3.25 million shares. Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations.

Has PSEC Found The Bottom and Ready To Move Up? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/